GlassScriptPhysician profile
Harish Shownkeen
NPI 1851311450
$13,736.54
in general payments reported to CMS, 2019-2025
10 companies · $3,248 in 2025
The $3,248 reported for 2025 was more than what 81% of Vascular & Interventional Radiology providers received nationally (typical 2025 total: $537).
See the full distribution for Vascular & Interventional Radiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,942 · 2020: $1,466 · 2021: $667 · 2022: $2,008 · 2023: $400 · 2024: $1,005 · 2025: $3,248.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,884 · Travel and Lodging: $1,769.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,883.97 |
| Travel and Lodging | $1,769.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $8,810.90 | 2019-2025 | Smart Coil, Indigo System, Penumbra System |
| Microvention, INC. | $1,977.83 | 2019-2025 | Web Aneurysm Embolization System, Web Detachment Controller, Tubing Kit - Stroke |
| Rapid Medical LTD | $1,807.50 | 2022-2024 | Comaneci 17, Tigertriever 17 Revascularization Device |
| Stryker Corporation | $471.06 | 2019-2025 | Surpass Evolve, Target |
| Siemens Medical Solutions USA, INC. | $311.67 | 2021 | |
| Depuy Synthes Sales INC. | $155.38 | 2019 | |
| Medtronic USA, INC. | $113.81 | 2020 | |
| Medtronic, INC. | $40.97 | 2021 | |
| Portola Pharmaceuticals, LLC | $26.49 | 2019 | |
| Cardinal Health 200 LLC | $20.93 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Harish Shownkeen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.